Rolf‐Peter Mueller

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Martin Köcher, Riccardo Soffietti, Ufuk Abacıoğlu et al. · Journal of Clinical Oncology · 2010 · 2K citations · Full text

Medicine, Oncology, Surgery +17

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

S. Staar, Volker Rudat, Hartmut Stuetzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 359 citations

Medicine, Oncology, Radiation Oncology +13

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

Sandra Collette, Laurence Collette, Tom Budiharto et al. · European Journal of Cancer · 2008 · 224 citations

Medicine, Oncology, Breast Oncology +12

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Carsten Kobe, Markus Dietlein, Jeremy Franklin et al. · Blood · 2008 · 204 citations · Full text

Medicine, Oncology, Radiology +17

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Volker Diehl et al. · Journal of Clinical Oncology · 2011 · 190 citations

Medicine, Oncology, Radiation Oncology +11